Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO

INTRODUCTION: People living with multidrug-resistant tuberculosis currently have few options for effective treatment and cure. Regimens that are available are toxic, may involve injections and take up to 2 years to complete treatment, with success rates as low as 50%. The TB-PRACTECAL trial is evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Stringer, Beverley, Lowton, Karen, James, Nicola, Nyang'wa, Bern-Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422308/
https://www.ncbi.nlm.nih.gov/pubmed/34489263
http://dx.doi.org/10.1136/bmjopen-2020-043954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422308/
https://www.ncbi.nlm.nih.gov/pubmed/34489263
http://dx.doi.org/10.1136/bmjopen-2020-043954

Ejemplares similares